Skip to main content
29 June, 2023

Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

It is with pride that our Founder & CEO Stefano Lo Priore participated in a new episode with Carter & Benson on entrepreneurial excellence.

Hyris continues along its journey and the presence of our CEO in this series of interviews confirms the goodness of the our direction.

We thank Carter & Benson William Griffini Chiara Arosio Lorenzo Bassi for the opportunity.

Here the full video of the interview.


  • Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

  • Hyris and Singlabs signed a distributorship agreement for Singapore

  • Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

  • Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine

  • Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia

  • Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2

  • Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich

  • A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.

  • Hyris and its network want to make pragmatic impact Helping Ukrainian Families

  • Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.